<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03655041</url>
  </required_header>
  <id_info>
    <org_study_id>24WKBA</org_study_id>
    <nct_id>NCT03655041</nct_id>
  </id_info>
  <brief_title>24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males</brief_title>
  <official_title>24-Weeks of β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although β-alanine (BA) has been shown to be an effective ergogenic aid, little information
      exists on the safety of chronic supplementation despite potential concerns. The aim of this
      study was to investigate the effects of chronic BA supplementation on muscle taurine content,
      blood clinical markers and sensory side-effects during 24 weeks of BA supplementation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2013</start_date>
  <completion_date type="Actual">December 15, 2017</completion_date>
  <primary_completion_date type="Actual">December 15, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle taurine content in mmol/kg</measure>
    <time_frame>Up to 24 weeks</time_frame>
    <description>Change in the content of taurine in muscle will be determined using High-Pressure Liquid Chromatography of muscle biopsies</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aspartate transaminase; alanine aminotransferase; alkaline phosphatase; lactate dehydrogenase and creatine kinase in U/L</measure>
    <time_frame>Up to 24 weeks</time_frame>
    <description>Aspartate transaminase; alanine aminotransferase; alkaline phosphatase; lactate dehydrogenase and creatine kinase will be analysed from venous blood samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Albumin; globulin; creatinine in mg/dL</measure>
    <time_frame>Up to 24 weeks</time_frame>
    <description>Albumin; globulin; creatinine will be analysed from venous blood samples</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Sports Nutritional Physiological Phenomena</condition>
  <arm_group>
    <arm_group_label>Beta-Alanine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6.4 g/day of beta-alanine for 24 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>6.4 g/day of maltodextrin for 24 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Beta-alanine</intervention_name>
    <description>Beta-alanine in sustained-release tablets to increase muscle carnosine content</description>
    <arm_group_label>Beta-Alanine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Maltodextrin is used as a placebo as it does not lead to any increases in muscle carnosine</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy males

        Exclusion Criteria:

          -  Smokers

          -  Chronic disease

          -  Prior or current use of steroids

          -  Use of creatine in the last 6 months

          -  Use of beta-alanine in the last 6 months
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Gualano, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 28, 2018</study_first_submitted>
  <study_first_submitted_qc>August 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <last_update_submitted>August 29, 2018</last_update_submitted>
  <last_update_submitted_qc>August 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Bruno Gualano</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Physiological Phenomena</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

